Former FTX CEO Sam Bankman-Fried Requests to Testify in Trial
In a recent filing, Sam Bankman-Fried’s lawyers have made new requests of the judge as his trial enters its third week. One of these requests involves the possibility of Bankman-Fried testifying in his own case. The filing also highlights the fact that Bankman-Fried has been unable to take his prescribed medication during the trial, which has affected his ability to remain focused.
Bankman-Fried’s Need for Medication
According to the filing, Bankman-Fried’s primary counsel, Mark Cohen, stated that his client requires his prescribed medication to perform at his best, particularly as the defense case is approaching. The prosecution is expected to rest its case by October 27, after which Cohen and his co-counsels will present their defense.
Possibility of Testimony
The defense raised the possibility of Bankman-Fried testifying but emphasized that he would need access to his medication in order to meaningfully participate in the presentation of their case. To address this issue, Bankman-Fried’s lawyers plan to provide him with an extended-release dose of Adderall before trial. However, they are uncertain if this solution will effectively help him focus throughout the day.
Trial Adjournment or Medication Allowance
If the proposed solution fails, Bankman-Fried’s lawyers have requested a one-day adjournment on October 17 to find a lasting solution. Alternatively, they have asked Judge Lewis Kaplan to allow Cohen to administer the prescribed dose of Adderall on trial days.
Prosecution and Defense Disagreements Over Witness Examination
The defense has faced objections during cross-examination due to questions deemed irrelevant by the prosecution. In response, the defense filed a letter to Judge Kaplan, requesting the freedom to present their version of the facts and let the jury decide. The prosecution, however, filed a letter opposing this motion, arguing that the court had already addressed issues related to the case theory before the trial and should reject the defense’s attempt to seek reconsideration.
Hot Take: Bankman-Fried’s Trial Challenges
As Sam Bankman-Fried’s trial continues, his lawyers have raised concerns about his inability to take prescribed medication and have requested solutions. This highlights the importance of ensuring that defendants have access to necessary medical support during legal proceedings. Additionally, disagreements between the prosecution and defense over witness examination further complicate the trial. These challenges underscore the complexities of legal proceedings and the need for fair and comprehensive processes to ensure justice is served.